These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24717377)

  • 1. Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): a doubly randomized preference trial.
    Le QA; Doctor JN; Zoellner LA; Feeny NC
    J Clin Psychiatry; 2014 Mar; 75(3):222-30. PubMed ID: 24717377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.
    Zoellner LA; Roy-Byrne PP; Mavissakalian M; Feeny NC
    Am J Psychiatry; 2019 Apr; 176(4):287-296. PubMed ID: 30336702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.
    Rauch SAM; Kim HM; Powell C; Tuerk PW; Simon NM; Acierno R; Allard CB; Norman SB; Venners MR; Rothbaum BO; Stein MB; Porter K; Martis B; King AP; Liberzon I; Phan KL; Hoge CW
    JAMA Psychiatry; 2019 Feb; 76(2):117-126. PubMed ID: 30516797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?
    Cooper AA; Zoellner LA; Roy-Byrne P; Mavissakalian MR; Feeny NC
    J Consult Clin Psychol; 2017 Sep; 85(9):873-882. PubMed ID: 28504542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD).
    Le QA; Doctor JN; Zoellner LA; Feeny NC
    Qual Life Res; 2018 Jun; 27(6):1555-1562. PubMed ID: 29541927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating "types" of treatment dropout: Nonstarters in an RCT of prolonged exposure versus sertraline.
    Kline AC; Baier AL; Klein AB; Feeny NC; Zoellner LA
    Behav Res Ther; 2020 Dec; 135():103750. PubMed ID: 33035741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.
    Rauch SAM; Kim HM; Lederman S; Sullivan G; Acierno R; Tuerk PW; Simon NM; Venners MR; Norman SB; Allard CB; Porter KE; Martis B; Bui E; Baker AW;
    J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34133087
    [No Abstract]   [Full Text] [Related]  

  • 8. "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.
    Chen JA; Keller SM; Zoellner LA; Feeny NC
    J Nerv Ment Dis; 2013 Aug; 201(8):691-7. PubMed ID: 23896851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT).
    Le QA; Doctor JN; Zoellner LA; Feeny NC
    Health Qual Life Outcomes; 2013 Apr; 11():59. PubMed ID: 23587015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged Exposure and Sertraline Treatments for Posttraumatic Stress Disorder Also Improve Multiple Indicators of Social Functioning.
    Graham B; Garcia NM; Bergman HE; Feeny NC; Zoellner LA
    J Trauma Stress; 2020 Aug; 33(4):488-499. PubMed ID: 32662191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpersonal psychotherapy versus sertraline for women with posttraumatic stress disorder following recent sexual assault: a randomized clinical trial.
    Proença CR; Markowitz JC; Coimbra BM; Cogo-Moreira H; Maciel MR; Mello AF; Mello MF
    Eur J Psychotraumatol; 2022; 13(2):2127474. PubMed ID: 36267873
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine.
    Peveler R; Kendrick T; Buxton M; Longworth L; Baldwin D; Moore M; Chatwin J; Goddard J; Thornett A; Smith H; Campbell M; Thompson C
    Health Technol Assess; 2005 May; 9(16):1-134, iii. PubMed ID: 15876362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosage, effectiveness, and safety of sertraline treatment for posttraumatic stress disorder in a Japanese clinical setting: a retrospective study.
    Kamo T; Maeda M; Oe M; Kato H; Shigemura J; Kuribayashi K; Hoshino Y
    BMC Psychiatry; 2016 Dec; 16(1):434. PubMed ID: 27923359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure-based treatments for childhood abuse-related post-traumatic stress disorder in adults: a health-economic evaluation.
    Kullberg MJ; Schoorl M; Oprel DAC; Hoeboer CM; Smit F; van der Does W; de Kleine RA; van Minnen A; van den Hout W
    Eur J Psychotraumatol; 2023; 14(1):2171752. PubMed ID: 37052103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: Assessor-blinded, randomized controlled study.
    Feng B; Zhang Y; Luo LY; Wu JY; Yang SJ; Zhang N; Tan QR; Wang HN; Ge N; Ning F; Zheng ZL; Zhu RM; Qian MC; Chen ZY; Zhang ZJ
    Psychiatry Clin Neurosci; 2019 Apr; 73(4):179-186. PubMed ID: 30565342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is implementation of the 2013 Australian treatment guidelines for posttraumatic stress disorder cost-effective compared to current practice? A cost-utility analysis using QALYs and DALYs.
    Mihalopoulos C; Magnus A; Lal A; Dell L; Forbes D; Phelps A
    Aust N Z J Psychiatry; 2015 Apr; 49(4):360-76. PubMed ID: 25348698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
    Schneier FR; Campeas R; Carcamo J; Glass A; Lewis-Fernandez R; Neria Y; Sanchez-Lacay A; Vermes D; Wall MM
    Depress Anxiety; 2015 Aug; 32(8):570-9. PubMed ID: 26115513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden gains in prolonged exposure and sertraline for chronic PTSD.
    Jun JJ; Zoellner LA; Feeny NC
    Depress Anxiety; 2013 Jul; 30(7):607-13. PubMed ID: 23633445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder.
    Armstrong EP; Skrepnek GH; Haim Erder M
    Curr Med Res Opin; 2007 Feb; 23(2):251-8. PubMed ID: 17288678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providing a treatment rationale for PTSD: does what we say matter?
    Feeny NC; Zoellner LA; Kahana SY
    Behav Res Ther; 2009 Sep; 47(9):752-60. PubMed ID: 19616197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.